Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT) - Top-Institutions - MDSpire

Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

  • By

  • Tobias Alexander

  • Raffaella Greco

  • May 16, 2022

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Brussels, Belgium

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Autoimmune Diseases
    • Cellular Therapies

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Autoimmune Diseases

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Autoimmune Disorders

  • #4

    University College London Hospitals (UCLH)
    University College London Hospitals (UCLH)

    London, England

    Key Differentiators

    • Stem Cell Transplantation
    • Autoimmune Diseases
    • Immunology

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Autoimmune Diseases
    • Cellular Therapy

Original Source(s)

Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

  • by Tobias Alexander, Raffaella Greco

  • May 16, 2022

Related Content

Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP)